利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

8 条记录 (耗时 0.02 秒)

    CATALYST CARRIER
    1.
    发明申请
    CATALYST CARRIER 审中-公开
    催化载体

    公开(公告)号：US20100056370A1

    公开(公告)日：2010-03-04

    申请号：US12548771

    申请日：2009-08-27

    申请人： Yasushige Shigyo ,  Tomohiro Yamamoto ,  Kenichi Imagawa ,  Takeshi Minami

    发明人： Yasushige Shigyo ,  Tomohiro Yamamoto ,  Kenichi Imagawa ,  Takeshi Minami

    IPC分类号： B01J21/04

    CPC分类号： B01J32/00 ,  B01J21/04 ,  B01J21/10 ,  B01J35/0006 ,  B01J35/04 ,  B01J37/0244

    摘要： A catalyst carrier which includes a catalyst support layer containing an alkaline earth metal and/or an alkali metal disposed on an alumina substrate. The alkaline earth metal and/or the alkali metal is suppressed or prevented from diffusing into the substrate to react with alumina in the substrate. A catalyst support layer 3 that contains an alkaline earth metal and/or an alkali metal is formed on a surface of an alumina substrate 1 having a three-dimensional network structure. A zirconia layer 2 consisting of zirconia and/or stabilized zirconia is disposed between the substrate 1 and the catalyst support layer 3. The zirconia layer 2 has a thickness of 3 μm or more in a region of at least 65% of the substrate surface. The zirconia layer suppresses or prevents the alkaline earth metal and/or the alkali metal in the catalyst support layer from diffusing into the substrate.

    摘要翻译： 一种催化剂载体，其包含含有设置在氧化铝基底上的碱土金属和/或碱金属的催化剂载体层。 碱土金属和/或碱金属被抑制或阻止扩散到基底中以与基底中的氧化铝反应。 在具有三维网状结构的氧化铝基板1的表面上形成含有碱土金属和/或碱金属的催化剂载体层3。 由氧化锆和/或稳定氧化锆构成的氧化锆层2设置在基板1和催化剂载体层3之间。氧化锆层2在基板表面的至少65％的区域中具有3μm以上的厚度。 氧化锆层抑制或防止催化剂载体层中的碱土金属和/或碱金属扩散到基材中。

    Antibodies to human leukemia virus-related peptides and a process for production of the antibodies
    4.
    发明授权
    Antibodies to human leukemia virus-related peptides and a process for production of the antibodies 失效
    人类白血病病毒相关肽的抗体和抗体的制备方法

    公开(公告)号：US4804746A

    公开(公告)日：1989-02-14

    申请号：US713659

    申请日：1985-03-19

    申请人： Mitsuaki Yoshida ,  Haruo Sugano ,  Fumio Shimizu ,  Kenichi Imagawa

    发明人： Mitsuaki Yoshida ,  Haruo Sugano ,  Fumio Shimizu ,  Kenichi Imagawa

    IPC分类号： C07K14/15 ,  C07K16/10 ,  C07K15/14 ,  A61K39/395

    CPC分类号： C07K14/005 ,  C07K16/1036 ,  C12N2740/14022 ,  Y10S530/806 ,  Y10S930/221

    摘要： An antibody of a human leukemia virus-related peptide obtained by collecting an antibody produced in a mammal body by administering to the mammal an antigen prepared by reacting a human leukemia virus-related peptide selected from the group consisting of:(a) a peptide represented by formula (1):H-Tyr-Val-Glu-Pro-Thr-Ala-Pro-Gln-Val-Leu-H (1)(b) a peptide represented by formula (2): psR-Ile-Pro-His-Pro-Lys-Asn-Ser-Ile-Gly-Gly-Glu-Val-OH (2)wherein R is the same as defined above;(c) a peptide represented by formula (3):R-Thr-Trp-Thr-Pro-Lys-Asp-Lys-Thr-Lys-Val-Leu-OH (3)wherein R is the same as defined above;(d) a peptide represented by formula (4):H-Val-Val-Gln-Pro-Lys-Lys-Pro-Pro-Pro-Tyr-OH (4)(e) a peptide represented by formula (5):R-Met-Gly-Gln-Ile-Phe-Ser-Arg-Ser-Ala-Ser-Pro-OH (5)wherein R is the same as defined above; and(f) a peptide represented by formula (6):H-Tyr-Pro-Glu-Gly-Thr-Pro-Lys-Asp-Pro-Ile-Leu-Arg-Ser-Leu-OH (6)as a hapten, with a carrier in the presence of a haptencarrier binding agent.

    摘要翻译： 通过对哺乳动物体内产生的抗体进行收集而获得的人类白血病病毒相关肽的抗体，其通过向哺乳动物施用通过使人白血病病毒相关肽反应而制备的抗原，所述人白血病病毒相关肽选自：（a） 式（1）表示的肽：H-Tyr-Val-Glu-Pro-Thr-Ala-Pro-Gln-Val-Leu-H（1）（b）由式（2）表示的肽：ps R-Ile-Pro -His-Pro-Lys-Asn-Ser-Ile-Gly-Gly-Glu-Val-OH（2）其中R与上述定义相同; （c）由式（3）表示的肽：R-Thr-Trp-Thr-Pro-Lys-Asp-Lys-Thr-Lys-Val-Leu-OH（3）其中R与上述定义相同; （d）由式（4）表示的肽：H-Val-Val-Gln-Pro-Lys-Lys-Pro-Pro-Pro-Tyr-OH（4）（e）由式（5）表示的肽： R-Met-Gly-Gln-Ile-Phe-Ser-Arg-Ser-Ala-Ser-Pro-OH（5）其中R与上述定义相同; 和（f）由式（6）表示的肽：作为半抗原的H-Tyr-Pro-Glu-Gly-Thr-Pro-Lys-Asp-Pro-Ile-Leu-Arg-Ser-Leu-OH 在载体中存在半载体结合剂。

    Spinel type compound oxide and method of manufacturing the same
    7.
    发明授权
    Spinel type compound oxide and method of manufacturing the same 有权
    尖晶石型复合氧化物及其制造方法

    公开(公告)号：US06218335B1

    公开(公告)日：2001-04-17

    申请号：US09359134

    申请日：1999-07-23

    申请人： Yoshimi Okada ,  Kenichi Imagawa ,  Susumu Yamamoto

    发明人： Yoshimi Okada ,  Kenichi Imagawa ,  Susumu Yamamoto

    IPC分类号： B01J2302

    CPC分类号： C01G53/00 ,  B01J23/005 ,  B01J35/1019 ,  B01J35/1042 ,  B01J35/1061 ,  B01J35/108 ,  B01J37/0201 ,  C01G3/00 ,  C01G9/00 ,  C01G51/00 ,  C01G53/006 ,  C01P2002/32 ,  C01P2002/72 ,  C01P2002/74 ,  C01P2004/82 ,  C01P2006/12 ,  C01P2006/14 ,  C01P2006/16 ,  C01P2006/17 ,  Y10S502/524

    摘要： A porous spinel type oxide shows a large surface area and a uniform micro-porous structure. The oxide is expressed by general formula MO—Al2O3 and shows a surface area per unit weight of not less than 80 m2/g. Such a porous spinel type compound oxide is obtained by impregnating a specific &ggr;-alumina carrier with a solution of a compound of metal element M capable of taking a valence of 2, drying the impregnated carrier and calcining it at a temperature of 600° C. or higher. The specific &ggr;-alumina carrier shows a surface area per unit weight of not less than 150 m2/g, a micro-pore volume per unit weight of not less than 0.55 cm3/g and an average micro-pore diameter between 90 and 200 angstroms. The micro-pores with a diameter between 90 and 200 angstroms occupy not less than 60% of the total micro-pore volume of the carrier.

    摘要翻译： 多孔尖晶石型氧化物显示出大的表面积和均匀的微孔结构。 氧化物由通式MO-Al 2 O 3表示，每单位面积的表面积不小于80m 2 / g。 通过用能量为2的金属元素M的化合物溶液浸渍特定的γ-氧化铝载体，干燥浸渍的载体并在600℃的温度下煅烧，可获得这种多孔尖晶石型复合氧化物。 或更高。 特定的γ-氧化铝载体表现出每单位重量的表面积不小于150m 2 / g，每单位重量的微孔体积不小于0.55cm 3 / g，平均微孔直径在90和200埃之间 。 直径在90和200埃之间的微孔占据载体总微孔体积的60％。

    Human leukemia virus-related peptides, antibodies of the peptides and a process for production of the antibodies
    8.
    发明授权
    Human leukemia virus-related peptides, antibodies of the peptides and a process for production of the antibodies 失效
    人白血病病毒相关肽，肽的抗体和抗体的制备方法

    公开(公告)号：US4525300A

    公开(公告)日：1985-06-25

    申请号：US535115

    申请日：1983-09-23

    申请人： Mitsuaki Yoshida ,  Haruo Sugano ,  Fumio Shimizu ,  Kenichi Imagawa

    发明人： Mitsuaki Yoshida ,  Haruo Sugano ,  Fumio Shimizu ,  Kenichi Imagawa

    IPC分类号： C07K14/15 ,  C07K16/10 ,  C07C103/52

    CPC分类号： C07K14/005 ,  C07K16/1036 ,  C12N2740/14022 ,  Y10S530/806 ,  Y10S930/221

    摘要： An antibody of a human leukemia virus-related peptide obtained by collecting an antibody produced in a mammal body by administering to the mammal an antigen prepared by reacting a human leukemia virus-related peptide selected from the group consisting of:(a) a peptide represented by formula (1):H-Tyr-Val-Glu-Pro-Thr-Ala-Pro-Gln-Val-Leu-H (1)(b) a peptide represented by formula (2):R-Ile-Pro-His-Pro-Lys-Asn-Ser-Ile-Gly-Gly-Glu-Val-OH (2)wherein R is the same as drefined above;(c) a peptide represented by formula (3):R-Thr-Trp-Thr-Pro-Lys-Asp-Lys-Thr-Lys-Val-Leu-OH (3)wherein R is the same as defined above;(d) a peptide represented by formula (4):H-Val-Val-Gln-Pro-Lys-Lys-Pro-Pro-Pro-Tyr-OH (4)(e) a peptide represented by formula (5):R-Met-Gly-Gln-Ile-Phe-Ser-Arg-Ser-Ala-Ser-Pro-OH (5)wherein R is the same as defined above; and(f) a peptide represented by formula (6):H-Tyr-Pro-Glu-Gly-Thr-Pro-Lys-Asp-Pro-Ile-Leu-Arg-Ser-Leu-OH (6)as a hapten, with a carrier in the presence of a hapten-carrier binding agent.

    摘要翻译： 通过对哺乳动物体内产生的抗体进行收集而获得的人类白血病病毒相关肽的抗体，其通过向哺乳动物施用通过使人白血病病毒相关肽反应而制备的抗原，所述人白血病病毒相关肽选自：（a） 式（1）表示的肽：H-Tyr-Val-Glu-Pro-Thr-Ala-Pro-Gln-Val-Leu-H（1）（b）由式（2）表示的肽：R-Ile-Pro- His-Pro-Lys-Asn-Ser-Ile-Gly-Gly-Glu-Val-OH（2）其中R与上述精制相同; （c）由式（3）表示的肽：R-Thr-Trp-Thr-Pro-Lys-Asp-Lys-Thr-Lys-Val-Leu-OH（3）其中R与上述定义相同; （d）由式（4）表示的肽：H-Val-Val-Gln-Pro-Lys-Lys-Pro-Pro-Pro-Tyr-OH（4）（e）由式（5）表示的肽： R-Met-Gly-Gln-Ile-Phe-Ser-Arg-Ser-Ala-Ser-Pro-OH（5）其中R与上述定义相同; 和（f）由式（6）表示的肽：作为半抗原的H-Tyr-Pro-Glu-Gly-Thr-Pro-Lys-Asp-Pro-Ile-Leu-Arg-Ser-Leu-OH 在载体中存在半抗原载体结合剂。